| Name: | Azilsartan Impurity K |
| Catalogue No. | VL252018 |
| CAS No. | 1442400-68-1 |
| Molecular Formula | C23H16N4O5 |
| Molecular Weight | 428.41 |
| Status | In-stock |
| IUPAC Name | 2-oxo-3-((2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-yl)methyl)-2,3-dihydro-1H-benzo[d]imidazole-4-carboxylic acid |
| Description | Azilsartan Impurity K (CAS No: 1442400-68-1) or 2-oxo-3-((2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-yl)methyl)-2,3-dihydro-1H-benzo[d]imidazole-4-carboxylic acid, Azilsartan Impurity K is an impurity of Azilsartan, it acts as to binds to AT1 receptors as an antagonist, blocking vasoconstrictor and aldosterone-secreting effects of angiotensin II. it belongs to an antihypertensive class. |
| References | Jones, Jocelyn D., et al. “Azilsartan Medoxomil (Edarbi).” Pharmacy and Therapeutics, vol. 36, no. 10, 1 Oct. 2011, pp. 634–640, www.ncbi.nlm.nih.gov/pmc/articles/PMC3278144/. Accessed 28 Jan. 2022. |
